Literature DB >> 26883537

Neuropathic osteoarthropathy with and without superimposed osteomyelitis in patients with a diabetic foot.

Antonio Leone1, Victor N Cassar-Pullicino2, Alessia Semprini3, Laura Tonetti3, Nicola Magarelli3, Cesare Colosimo3.   

Abstract

Soft tissue and bone infection involving the foot is one of the most common long-term complications of diabetes mellitus, implying a serious impairment in quality of life for patients in the advanced stages of the disease. Neuropathic osteoarthropathy often coexists and differentiating between these two entities is commonly challenging, but crucial, as the management may differ substantially. The importance of correct diagnosis cannot be understated and effective management requires a multidisciplinary approach owing to the complicated nature of therapy in such patients. A missed diagnosis has a high likelihood of major morbidity for the patient, including limb amputation, and over-diagnosis results in a great socioeconomic challenge for healthcare systems, the over-utilization of healthcare resources, and the unwise use of antibiotics. Diagnosis is largely based on clinical signs supplemented by various imaging modalities such as radiography, MR imaging, and hybrid imaging techniques such as F-18 fluorodeoxyglucose-positron emission tomography. In the interests of the management of diabetic foot complications, this review article is aimed on the one hand at providing radiologists with important clinical knowledge, and on the other hand to equip clinicians with relevant radiological semiotics.

Entities:  

Keywords:  Diabetes mellitus; Diabetic foot; F-18 FDG-PET/CT; MR imaging; Neuropathic osteoarthropathy; Osteomyelitis

Mesh:

Year:  2016        PMID: 26883537     DOI: 10.1007/s00256-016-2339-1

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  127 in total

1.  Response of Charcot's arthropathy to contact casting: assessment by quantitative techniques.

Authors:  M McGill; L Molyneaux; T Bolton; K Ioannou; R Uren; D K Yue
Journal:  Diabetologia       Date:  2000-04       Impact factor: 10.122

2.  Surgical reconstruction of the diabetic Charcot foot: internal, external or combined fixation?

Authors:  John J Stapleton; Thomas Zgonis
Journal:  Clin Podiatr Med Surg       Date:  2012-05-18       Impact factor: 1.231

3.  18F-FDG and diabetic foot infections: the verdict is...

Authors:  Christopher J Palestro
Journal:  J Nucl Med       Date:  2011-06-16       Impact factor: 10.057

4.  Diagnosis of infection in the diabetic foot using (18)F-FDG PET/CT: a sweet alternative?

Authors:  Gopinath Gnanasegaran; Sanjay Vijayanathan; Ignac Fogelman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10       Impact factor: 9.236

5.  FDG PET/CT imaging in the diagnosis of osteomyelitis in the diabetic foot.

Authors:  Olga Kagna; Saher Srour; Eyal Melamed; Daniela Militianu; Zohar Keidar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-17       Impact factor: 9.236

6.  Oral antimicrobial therapy for diabetic foot osteomyelitis.

Authors:  John M Embil; Greg Rose; Elly Trepman; Mary Cheang M Math; Frank Duerksen; J Neil Simonsen; Lindsay E Nicolle
Journal:  Foot Ankle Int       Date:  2006-10       Impact factor: 2.827

7.  Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders?

Authors:  H M Zhuang; A Cortés-Blanco; M Pourdehnad; L E Adam; A J Yamamoto; R Martínez-Lázaro; J H Lee; J C Loman; M D Rossman; A Alavi
Journal:  Nucl Med Commun       Date:  2001-10       Impact factor: 1.690

Review 8.  The role of nuclear medicine in the diagnosis of common and specific diabetic infections.

Authors:  Nikolaos Papanas; Athanassios Zissimopoulos; Efstratios Maltezos
Journal:  Hell J Nucl Med       Date:  2010 May-Aug       Impact factor: 1.102

9.  Impact of achilles tendon lengthening on functional limitations and perceived disability in people with a neuropathic plantar ulcer.

Authors:  Michael J Mueller; David R Sinacore; Mary Kent Hastings; Donovan J Lott; Michael J Strube; Jeffrey E Johnson
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

Review 10.  Diabetic foot osteomyelitis.

Authors:  A Hartemann-Heurtier; E Senneville
Journal:  Diabetes Metab       Date:  2008-01-31       Impact factor: 6.041

View more
  6 in total

1.  Dynamic contrast-enhanced magnetic resonance imaging for differentiating osteomyelitis from acute neuropathic arthropathy in the complicated diabetic foot.

Authors:  Dan Liao; Liqiu Xie; Yongliang Han; Silin Du; Hansheng Wang; Chun Zeng; Yongmei Li
Journal:  Skeletal Radiol       Date:  2018-04-13       Impact factor: 2.199

2.  The role of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for the diagnosis of diabetic foot osteomyelitis: a preliminary report.

Authors:  Shashank Raj; Mahesh Prakash; Ashu Rastogi; Anindita Sinha; Manavjit Singh Sandhu
Journal:  Pol J Radiol       Date:  2022-05-23

Review 3.  Osteomyelitis of the lower extremity: pathophysiology, imaging, and classification, with an emphasis on diabetic foot infection.

Authors:  Jacob C Mandell; Bharti Khurana; Jeremy T Smith; Gregory J Czuczman; Varand Ghazikhanian; Stacy E Smith
Journal:  Emerg Radiol       Date:  2017-10-20

Review 4.  Bone and soft tissue infections in patients with diabetic foot.

Authors:  Antonio Leone; Carla Vitiello; Consolato Gullì; Anna K Sikora; Silvia Macagnino; Cesare Colosimo
Journal:  Radiol Med       Date:  2019-10-24       Impact factor: 3.469

Review 5.  Magnetic resonance imaging of musculoskeletal infections.

Authors:  Jennifer S Weaver; Imran M Omar; Winnie A Mar; Andrea S Klauser; Blair A Winegar; Gary W Mlady; Wendy E McCurdy; Mihra S Taljanovic
Journal:  Pol J Radiol       Date:  2022-03-05

Review 6.  Molecular Imaging of Diabetic Foot Infections: New Tools for Old Questions.

Authors:  Camilo A Ruiz-Bedoya; Oren Gordon; Filipa Mota; Sudhanshu Abhishek; Elizabeth W Tucker; Alvaro A Ordonez; Sanjay K Jain
Journal:  Int J Mol Sci       Date:  2019-11-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.